Nevro Corp. (NVRO)
NYSE: NVRO · IEX Real-Time Price · USD
9.10
-0.37 (-3.91%)
At close: Jul 19, 2024, 12:00 AM
9.32
+0.22 (2.42%)
Pre-market: Jul 22, 2024, 8:56 AM EDT
Nevro Employees
Nevro had 1,215 employees as of December 31, 2023. The number of employees increased by 128 or 11.78% compared to the previous year.
Employees
1,215
Change (1Y)
128
Growth (1Y)
11.78%
Revenue / Employee
$354,523
Profits / Employee
-$67,978
Market Cap
334.23M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
ModivCare | 21,200 |
Kamada | 378 |
Xeris Biopharma Holdings | 377 |
ADC Therapeutics | 274 |
Nautilus Biotechnology | 167 |
AC Immune | 161 |
Cabaletta Bio | 103 |
Inozyme Pharma | 59 |
NVRO News
- 10 days ago - Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 - PRNewsWire
- 12 days ago - Nevro to Report Second-Quarter 2024 Financial Results and Host Earnings Conference Call on August 6, 2024 - PRNewsWire
- 5 weeks ago - Nevro to Present at Truist Securities MedTech Conference - PRNewsWire
- 2 months ago - Nevro to Present at BofA Securities 2024 Healthcare Conference - PRNewsWire
- 2 months ago - Nevro Reports First-Quarter 2024 Financial Results - PRNewsWire
- 3 months ago - Nevro to Report First-Quarter 2024 Financial Results and Host Earnings Conference Call on May 7, 2024 - PRNewsWire
- 5 months ago - Nevro Receives FDA 510(k) Clearance to Use SI Fixation System Without Need to Include Lateral Screw - PRNewsWire
- 5 months ago - Nevro Enters Into Cooperation Agreement With Engaged Capital - PRNewsWire